Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Other financing activities (2021)

Serina Therapeutics (SER) has disclosed Other financing activities for 1 consecutive years, with -$250000.0 as the latest value for Q1 2021.

  • Quarterly Other financing activities changed N/A to -$250000.0 in Q1 2021 from the year-ago period, while the trailing twelve-month figure was -$250000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at -$250000.0 for FY2021, 259.24% down from the prior year.
  • Other financing activities hit -$250000.0 in Q1 2021 for Serina Therapeutics.
  • In the past five years, Other financing activities ranged from a high of -$250000.0 in Q1 2021 to a low of -$250000.0 in Q1 2021.